Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -5.740% | 14.486% | 15.023% | -12.500% | 21.287% | 166.015% | - |
| Larimar Therapeutics Inc. | -2.160% | -2.113% | -18.235% | -20.571% | -16.265% | -31.863% | -82.270% |
| Vaxart Inc. | 10.000% | 120.588% | 114.286% | -20.000% | 114.286% | -46.352% | -88.889% |
Comments
News
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (NASDAQ:XRAY), a major player in dental products and technologies, released its second quarter results on August 7, 2025. The company reported GAAP revenue of $936 million and
